Data provided by Nasdaq. Minimum 15 minutes delayed.
August 30, 2017
NantHealth and Asia Genomics Announce Global Expansion of GPS CancerTM in Southeast Asia
Partnership enables oncologists in Singapore, Malaysia, Thailand, Vietnam and The Philippines to offer patients a new standard of care through GPS Cancer NantHealth expands global GPS Cancer launch with test now also internationally available in Israel, Mexico, Italy and the Middle East CULVER CITY, Calif. & SINGAPORE--(BUSINESS WIRE)--Aug. 30, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced that it has ente...
August 10, 2017
NantHealth Reports 2017 Second Quarter Financial Results; Implements Plan to Focus on Core Competencies, Enhance Profitability and Position for Growth of Artificial Intelligence for Cancer Care
Restructuring Plan Implemented To Focus on Cancer Decision Support and Artificial Intelligence Platform Integration of Four Pillars: GPS Cancer, Eviti Clinical Decision Support, Connected Care and Provider/Payer Engagement Sale of Patient/Provider Portal to Allscripts Expected to Significantly Accelerate Timeline to Profitability ...
August 08, 2017
NantHealth to Report 2017 Second-Quarter Financial Results and Host Conference Call on Thursday, August 10
CULVER CITY, Calif.--(BUSINESS WIRE)--Aug. 8, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2017 second quarter on Thursday, August 10, 2017, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will...
|There are currently no events scheduled.|